Scientists Say They Have Developed A Tumor-Derived Plasma cfDNA Assay That Can Detect Early-Stage RCC

Renal & Urology News (8/7, Charnow) reported scientists “independently validated an assay for tumor-derived plasma cell-free DNA (cfDNA) that detects early-stage renal cell carcinoma (RCC) and demonstrated for the first time that this assay can accurately...